{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:22:52Z","timestamp":1778628172075,"version":"3.51.4"},"reference-count":43,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2021.2417","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T11:38:37Z","timestamp":1633693117000},"source":"Crossref","is-referenced-by-count":15,"title":["Addressing the importance of melanoma tumor\u2011infiltrating lymphocytes in disease progression and clinicopathological characteristics"],"prefix":"10.3892","volume":"15","author":[{"given":"Tatjana","family":"Zablocka","sequence":"first","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, University of Latvia, LV\u20111004 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Nikolajeva","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, University of Latvia, LV\u20111004 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madara","family":"Kreismane","sequence":"additional","affiliation":[{"name":"Latvian Biomedical Research and Study Centre, LV\u20111067 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dace","family":"Pjanova","sequence":"additional","affiliation":[{"name":"Latvian Biomedical Research and Study Centre, LV\u20111067 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergejs","family":"Isajevs","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, University of Latvia, LV\u20111004 Riga, Latvia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"issue":"9583","key":"key20220302131042_b1-MCO-15-6-02417","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249583","article-title":"Melanoma biomarkers and their potential application for in vivo diagnostic imaging modalities","volume":"21","author":"Hessler","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"e2020033","key":"key20220302131042_b2-MCO-15-6-02417","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1003a33","article-title":"Melanoma epidemiology and early detection in Europe: Diversity and disparities","volume":"10","author":"Forsea","year":"2020","journal-title":"Dermatol Pract Concept"},{"key":"key20220302131042_b3-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/07853890.2016.1145795","article-title":"Melanoma screening: A plan for improving early detection","volume":"48","author":"Shellenberger","year":"2016","journal-title":"Ann Med"},{"key":"key20220302131042_b4-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00428-013-1526-x","article-title":"Tissue prognostic biomarkers in primary cutaneous melanoma","volume":"464","author":"Mandal\u00e0","year":"2014","journal-title":"Virchows Arch"},{"key":"key20220302131042_b5-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/CMR.0000000000000293","article-title":"A small multimarker panel using simple immunohistochemistry methods is an adjunct to stage for cutaneous melanoma prognosis","volume":"26","author":"Romaine","year":"2016","journal-title":"Melanoma Res"},{"key":"key20220302131042_b6-MCO-15-6-02417","author":"Bolognia"},{"key":"key20220302131042_b7-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathol-012513-104658","article-title":"The molecular pathology of melanoma: An integrated taxonomy of melanocytic neoplasia","volume":"9","author":"Bastian","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"key20220302131042_b8-MCO-15-6-02417","author":"Elder"},{"key":"key20220302131042_b9-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1200\/JCO.2011.37.8539","article-title":"Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma","volume":"30","author":"Azimi","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20220302131042_b10-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/CMR.0000000000000164","article-title":"Tumor-infiltrating lymphocytes predict cutaneous melanoma survival","volume":"25","author":"Fortes","year":"2015","journal-title":"Melanoma Res"},{"key":"key20220302131042_b11-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"14759","DOI":"10.18632\/oncotarget.14736","article-title":"Clinicopathological significance of intratumoral and peritumoral lymphocytes and lymphocyte score based on the histologic subtypes of cutaneous melanoma","volume":"8","author":"Park","year":"2017","journal-title":"Oncotarget"},{"issue":"2105","key":"key20220302131042_b12-MCO-15-6-02417","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02105","article-title":"Tumor-infiltrating lymphocytes and their prognostic value in cutaneous melanoma","volume":"11","author":"Maibach","year":"2020","journal-title":"Front Immunol"},{"key":"key20220302131042_b13-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-017-0552-6","article-title":"Cancer immunotherapy: Beyond checkpoint blockade","volume":"3","author":"Dougan","year":"2018","journal-title":"Annu Rev Cancer Biol"},{"key":"key20220302131042_b14-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","article-title":"The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy","volume":"19","author":"Havel","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"key20220302131042_b15-MCO-15-6-02417","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2015","journal-title":"Science"},{"key":"key20220302131042_b16-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"key20220302131042_b17-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/0284186X.2020.1747636","article-title":"BRAF mutational status as a prognostic marker for survival in malignant melanoma: A systematic review and meta-analysis","volume":"59","author":"Ny","year":"2020","journal-title":"Acta Oncol"},{"key":"key20220302131042_b18-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/01.cmr.0000232300.22032.86","article-title":"NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: A study based on mutation screening by pyrosequencing","volume":"6","author":"Edlundh-Rose","year":"2006","journal-title":"Melanoma Res"},{"key":"key20220302131042_b19-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"36130","DOI":"10.18632\/oncotarget.9143","article-title":"Which melanoma patient carries a BRAF-mutation? A comparison of predictive models","volume":"7","author":"Eigentler","year":"2016","journal-title":"Oncotarget"},{"key":"key20220302131042_b20-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"631","DOI":"10.4149\/neo_2018_181006N740","article-title":"Clinical and prognostic significance of BRAF V600E mutation in non-metastatic cutaneous melanoma patients","volume":"66","author":"Tas","year":"2019","journal-title":"Neoplasma"},{"key":"key20220302131042_b21-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000505152","article-title":"Prognostic significance of tumor-infiltrating lymphocyte grade in melanoma: A meta-analysis","volume":"236","author":"Sun","year":"2020","journal-title":"Dermatology"},{"key":"key20220302131042_b22-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression","volume":"81","author":"Clark","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"key20220302131042_b23-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<427::AID-CNCR8>3.0.CO;2-G","article-title":"Predicting five-year outcome for patients with cutaneous melanoma in a population-based study","volume":"78","author":"Barnhill","year":"1996","journal-title":"Cancer"},{"key":"key20220302131042_b24-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1309\/WBF7-N8KH-71KT-RVQ9","article-title":"Risk assessment in localized primary cutaneous melanoma: A Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model","volume":"118","author":"Tuthill","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"key20220302131042_b25-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1200\/JCO.2006.08.9755","article-title":"Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma","volume":"25","author":"Taylor","year":"2007","journal-title":"J Clin Oncol"},{"key":"key20220302131042_b26-MCO-15-6-02417","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/000313481107700219","article-title":"Prognostic significance of tumor infiltrating lymphocytes in melanoma","volume":"77","author":"Burton","year":"2011","journal-title":"Am Surg"},{"key":"key20220302131042_b27-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ejca.2009.05.034","article-title":"Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database","volume":"45","author":"Mandala","year":"2009","journal-title":"Eur J Cancer"},{"key":"key20220302131042_b28-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1200\/JCO.2013.51.3002","article-title":"Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study","volume":"31","author":"Thomas","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20220302131042_b29-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma","volume":"77","author":"Clemente","year":"1996","journal-title":"Cancer"},{"key":"key20220302131042_b30-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.humpath.2016.07.008","article-title":"Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma","volume":"57","author":"Weiss","year":"2016","journal-title":"Hum Pathol"},{"key":"key20220302131042_b31-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1007\/s00432-021-03565-y","article-title":"Coexistence of regression and tumor infiltrating lymphocytes is associated with more favorable survival in melanoma","volume":"147","author":"Tas","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20220302131042_b32-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/CMR.0000000000000253","article-title":"Decreased tumor-infiltrating lymphocytes in nodular melanomas compared with matched superficial spreading melanomas","volume":"26","author":"Lin","year":"2016","journal-title":"Melanoma Res"},{"key":"key20220302131042_b33-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.molonc.2007.12.003","article-title":"Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site","volume":"1","author":"Platz","year":"2008","journal-title":"Mol Oncol"},{"key":"key20220302131042_b34-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/DAD.0000000000000241","article-title":"Clinicopathological characteristics and mutation profiling in primary cutaneous melanoma","volume":"37","author":"Yaman","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"key20220302131042_b35-MCO-15-6-02417","first-page":"225","article-title":"Clinicopathological characteristics of BRAF V600E mutated melanomas in the dalmatian region of croatia","volume":"27","author":"Bezi\u0107","year":"2019","journal-title":"Acta Dermatovenerol Croat"},{"key":"key20220302131042_b36-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5826\/dpc.0901a13","article-title":"BRAF mutation status in primary, recurrent, and metastatic malignant melanoma and its relation to histopathological parameters","volume":"9","author":"Spathis","year":"2019","journal-title":"Dermatol Pract Concept"},{"key":"key20220302131042_b37-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaad.2015.02.1113","article-title":"Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma","volume":"72","author":"Kim","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"key20220302131042_b38-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/pdm.0b013e318298c1d9","article-title":"Clinicopathologic findings and BRAF mutation in cutaneous melanoma in young adults","volume":"22","author":"Estrozi","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key20220302131042_b39-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.prp.2015.03.005","article-title":"Russian study of morphological prognostic factors characterization in BRAF-mutant cutaneous melanoma","volume":"211","author":"Aksenenko","year":"2015","journal-title":"Pathol Res Pract"},{"key":"key20220302131042_b40-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/PAT.0000000000000314","article-title":"FOXP3+ T regulatory lymphocytes in primary melanoma are associated with BRAF mutation but not with response to BRAF inhibitor","volume":"47","author":"Leslie","year":"2015","journal-title":"Pathology"},{"issue":"1834","key":"key20220302131042_b41-MCO-15-6-02417","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81330-4","article-title":"Tumor infiltrating lymphocyte clusters are associated with response to immune checkpoint inhibition in BRAF V600E\/K mutated malignant melanomas","volume":"11","author":"Klein","year":"2021","journal-title":"Sci Rep"},{"key":"key20220302131042_b42-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/bjd.12351","article-title":"Disease progression and patient survival are significantly influenced by BRAF protein expression in primary melanoma","volume":"169","author":"Safaee Ardekani","year":"2013","journal-title":"Br J Dermatol"},{"key":"key20220302131042_b43-MCO-15-6-02417","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jaad.2013.10.064","article-title":"Prognostic value of BRAF mutations in localized cutaneous melanoma","volume":"70","author":"Nagore","year":"2014","journal-title":"J Am Acad Dermatol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T11:11:33Z","timestamp":1646219493000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2021.2417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,10,8]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2021.2417","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]},"article-number":"255"}}